Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway

Immunology

Volumn 94, Issue 2, 1998, Pages 271-278

  Liversidge, J ^a   Dawson, R ^a   Dick, A D ^a   Forrester, J V ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; RETINA S ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL SURFACE; FEMALE; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; UVEORETINITIS;

ANIMALS; ANTIGEN PRESENTATION; ARRESTIN; AUTOANTIGENS; AUTOIMMUNE DISEASES; CATHEPSIN B; CELL DIVISION; CYSTEINE PROTEINASE INHIBITORS; EPITOPES; EYE PROTEINS; LYSOSOMES; RATS; RATS, INBRED STRAINS; RETINOL-BINDING PROTEINS; T-LYMPHOCYTES; UVEITIS, POSTERIOR;

EID: 0031860236     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00503.x     Document Type: Article

References (38)

1. FORRESTER J.V. (1991) Uveitis: pathogenesis. Lancet 388, 1498.
2. GERY I., MOCHIZUKI M. & NUSSENBLATT R.B. (1986) Retinal specific antigens and the immunopathogenic responses they provoke. Prog Ret Res 5, 75.
3. SHINOHARA T., DONOSO L.A., TSUDA M., YAMAKI K. & SINGH V.K. (1988) S-antigen: structure, function and experimental autoimmune uveitis (EAU). Prog Ret Res 8, 51.
4. CHADER G.J. (1989) Interphotoreceptor retinoid-binding protein (IRBP): a model protein for molecular biological and clinically relevant studies. Invest Ophthalmol Vis Sci 30, 7.
5. DONOSO L.A., YAMAKI K., MERRYMAN C.F., SHINOHARA T., YUE S. & SERY T. (1988) Human S-antigen: characterisation of uveitopathogenic sites. Curr Eye Res 7, 1077.
6. DONOSO L.A., MERRYMAN C.F., SERY T., SANDERS R., VRABEC T. & FONG S-L. (1989) Human interstitial retinoid binding protein, a potent uveitopathogenic agent for the induction of experimental autoimmune uveitis. J Immunol 143, 79.
7. CASPI R.R., ROBERGE F.G., MCALLISTER C.G. et al. (1986) T cell lines mediating experimental autoimmune uveoretinitis in the rat. J Immunol. 136, 928.
8. ADORINI L. & GUERY J.C. (1993) Suppression of T-cell activation by administration of MHC class II binding peptides. Immunology Series 59, 331.
9. ISSACS J. & DICK A.D. (1996) Short term immunosuppressive therapy and long term immunoregulation: promises and problems. Br J Ophthalmol 80, 1035.
10. KOZHICH A.T., KAWANO Y-I., EGWUAGU C.E. et al. (1994) A pathogenic autoimmune process targeted at a surrogate epitope. J Exp Med 190, 133.
11. GREGERSON D.S., FLING S.P., OBSRITCH W.F., MERRYMAN C.F. & DONOSO L.A. (1989) Identification of T cell recognition sites in S-antigen: dissociation of proliferative and pathogenic sites. Cell Immunol 123, 427.
12. MERRYMAN C.F., DONOSO L.A., ZHANG X., HEBER-KATZ E. & GREGERSON D.S. (1991) Characterisation of a new potent, immunopathogenic epitope in S-antigen that elicits T cells expressing Vβ8 and Vα2-like genes. J Immunol 146, 75.
13. SANTORO L., REBOUL A., JOURNET A.G. & COLOMB M.G. (1993) Major involvement of cathepsin B in the intracellular proteolytic processing of exogenous IgGs in U937 cells. Mol Immunol 30, 1033.
14. CHAIN B.M., BOU-GHARIUS G. & OLSEN I. (1989) Endopeptidase activities associated with the plasma membrane compartment of an antigen-presenting B cell. Clin Exp Immunol 75, 87.
15. MATSUNAGA Y., SAIBARA T., KIDO H. & KATUNUMA N. (1993) Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS 324, 325.
16. BARRETT A.J. (1986) An introduction to the proteinases. In: Proteinase inhibitors (eds A. J. Barrett & G. Salvesen), p. 3. Elsevier, Amsterdam.
17. LIVERSIDGE J. & FORRESTER J.V. (1992) Antigen processing and presentation in the eye: a review. Curr Eye Res 11 (suppl.), 49.
18. LIVERSIDGE J., THOMSON A.W., SEWELL, H.F. & FORRESTER J.V. (1987) EAU in the guinea-pig: inhibition of cell mediated immunity and Ia expression by cyclosporin A. Clin Exp Immunol 69, 591.
19. HARPER F.H., LIVERSIDGE J., THOMSON A.W. & FORRESTER J.V. (1992) Interphotoreceptor retinoid binding protein induced experimental autoimmune uveitis: an immunophenotypic analysis using alkaline phosphatase anti-alkaline phosphatase staining, dual immunofluorescence and confocal microscopy. Curr Eye Res 11 (suppl.), 129.
20. DICK A.D., CHENG Y.F., LIVERSIDGE J. & FORRESTER J.V. (1994) Immunoregulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye 8, 52.
21. RIESE R.J., WOLF P.R., BRÖMME D. et al. (1996) Essential role for cathepsin S in MHC class-2 associated invariant chain processing and peptide loading. Immunity 5, 357.
22. POLGAR L. & CSOMA C. (1987) Dissociation of ionising groups in the binding cleft inversely controls the endo- and exopeptidase activities of cathepsin B. J Biol Chem 262, 14448.
23. DAVIES P.J., DAVIES D.R., LEVITZKI A. et al. (1980) Transglutaminase is essential in receptor mediated endocytosis of α2 macroglobulin and polypeptide hormones. Nature 283, 162.
24. SCHMID S.L. & JACKSON M.R. (1994) Making Class II presentable. Nature 369, 103.
25. WATTS C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 115, 821.
26. WOLF P.R. & PLOEGH H.L. (1995) DM exchange mechanism. Nature 376, 464.
27. ANDERSON M.S., SWIER K., ARNESON L. & MILLER J. (1993) Enhanced antigen presentation in the absence of the invariant chain endosomal localisation signal. J Exp Med 178, 1959.
28. PINET V., VERGELLI M., MARTIN R., BAKKE O. & LONG E.O. (1995) Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375, 603.
29. AMIGORENA S., DRAKE J.R., WEBSTER P. & MELLMAN I. (1994) transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369, 113.
30. DENZIN L.K. & CRESSWELL P. (1995) HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155.
31. LANZAVECCIA A. & WATTS C. (1994) Peptide partners call the tune. Nature 371, 198.
32. SERCARZ E.E., LEHMANN P.V., AMETANI A., BENICHOU G., MILLER A. & MOUDGIL K. (1993) Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11, 729.
33. COLLINS D.S., UNANUE E.R. & HARDING C.V. (1991) Reduction of disulphide bonds within lysosomes is a keystep in antigen processing. J Immunol 147, 4054.
34. VERGELLI M., PINET V., VOGT A.B. et al. (1997) HLA-DR restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur J Immunol 27, 941.
35. CRESSWELL P. (1996) Invariant chain structure and MHC class II function. Cell 84, 505.
36. NICKERSON J.M., GOODMAN M., LIN Z.Y., CZELUSNIAK J. & MIAN I.S. (1997) Predicted structure, function, and evolution of the repeated domain present in interphotoreceptor binding protein (IRBP) and its homologues. Invest Ophthalmol Vis Sci 38, S3.
37. HARDING C.V. & UNANUE E.R. (1990) Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T cell stimulation. Nature 346, 574.
38. SINGH D.P., KIKUCHI T., SINGH V.K. & SHINOHARA T. (1994) A single amino acid substitution in core residues of S-antigen prevents experimental autoimmune uveoretinitis. J Immunol 152, 4699.